Replimune Group, Inc. (REPL)
NASDAQ
13.42
+0.38 (+2.91%)
Closed
Oct 9, 2026
Day's Range
12.8013.44
52 wk Range
1.5016.33
Financial Statements - REPL - Replimune Group, Inc.
Revenue
0
Net Income
-313.94M▼ 26.9%
EBITDA
-315.92M▼ 23.1%
Free Cash Flow
-284.56M▼ 43.0%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -318.31M | -259.85M | -232.85M | -174.16M | -115.14M | -77.14M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 12.68M | 20.91M | 24.12M | 4.33M | -669K | -662K |
| Pre Tax Income | -314.49M | -246.82M | -215.38M | -173.99M | -118.03M | -80.87M |
| Income Tax | -551K | 468K | 408K | 288K | 0 | - |
| Net Income | -313.94M | -247.29M | -215.79M | -174.28M | -118.03M | -80.87M |
| EPS Basic | -3.38 | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| EPS Diluted | -3.38 | -3.07 | -3.24 | -2.99 | -2.26 | -1.75 |
| Basic Shares Outstanding | 92.80M | 80.56M | 66.56M | 58.21M | 52.21M | 46.24M |
| Diluted Shares Outstanding | 92.80M | 80.56M | 66.56M | 58.21M | 52.21M | 46.24M |
| Ebit | -305.63M | -238.93M | -208.72M | -169.83M | -115.81M | -77.81M |
| Ebitda | -315.92M | -256.55M | -229.42M | -177.39M | -114.05M | -76.10M |
| Net Income Continuous Operations | -313.94M | -247.29M | -215.79M | -174.28M | -118.03M | -80.87M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
